Mark A. Glickman
2016
In 2016, Mark A. Glickman earned a total compensation of $2.1M as Chief Commercial Officer at Aralez Pharmaceuticals, a 147% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,861 |
|---|---|
| Option Awards | $63,989 |
| Salary | $385,000 |
| Stock Awards | $994,134 |
| Other | $536,653 |
| Total | $2,146,637 |
Glickman received $994.1K in stock awards, accounting for 46% of the total pay in 2016.
Glickman also received $166.9K in non-equity incentive plan, $64K in option awards, $385K in salary and $536.7K in other compensation.
Rankings
In 2016, Mark A. Glickman's compensation ranked 4,569th out of 14,075 executives tracked by ExecPay. In other words, Glickman earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,569 out of 14,075 | 68th |
Division Manufacturing | 1,622 out of 5,489 | 70th |
Major group Chemicals And Allied Products | 504 out of 1,895 | 73rd |
Industry group Drugs | 372 out of 1,538 | 76th |
Industry Pharmaceutical Preparations | 294 out of 1,176 | 75th |
Source: SEC filing on March 23, 2017.
Glickman's colleagues
We found four more compensation records of executives who worked with Mark A. Glickman at Aralez Pharmaceuticals in 2016.